Impact of the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology clinical practice guidelines for EGFR and ALK testing in lung cancer in Canada

被引：10
作者：
Ionescu, D. N. [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
CURRENT ONCOLOGY | 2013年 / 20卷 / 04期
关键词：
Lung cancer; College of American Pathologists; CAP; International Association for the Study of Lung Cancer; IASLC; Association for Molecular Pathology; AMP; guidelines; GROWTH-FACTOR RECEPTOR; EML4-ALK FUSION GENE; ACQUIRED-RESISTANCE; MUTATIONS; ADENOCARCINOMAS; CLASSIFICATION; IDENTIFICATION; REARRANGEMENT; GEFITINIB; SELECTION;
D O I：
10.3747/co.20.1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This paper summarizes the practical impact of the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology lung cancer biomarkers guidelines on the lung cancer approach in Canada, providing possible practical solutions for other similar health care systems in which scientific reality needs to be constantly balanced against economic reality.
引用
收藏
页码：220 / 226
页数：7
相关论文
共 34 条
  • [1] [Anonymous], 2011, LUNG CANC B IN PRESS
  • [2] [Anonymous], NCCN CLIN PRACT GUID
  • [3] The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
    Atherly, A. J.
    Camidge, D. R.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (06) : 1100 - 1106
  • [4] Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor - Mutant lung adenocarcinomas with acquired resistance to kinase inhibitors
    Balak, Marissa N.
    Gong, Yixuan
    Riely, Gregory J.
    Somwar, Romel
    Li, Allan R.
    Zakowski, Maureen F.
    Chiang, Anne
    Yang, Guangli
    Ouerfelli, Ouathek
    Kris, Mark G.
    Ladanyi, Marc
    Miller, Vincent A.
    Pao, William
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (21) : 6494 - 6501
  • [5] Bosdet I, 2012, LAB INVEST, V92, p474A
  • [6] Cagle PT, 2011, ARCH PATHOL LAB MED, V135, P110, DOI 10.1043/2010-0567-RA.1
  • [7] Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non-Small-Cell Lung Carcinoma and is Antibody Dependent
    Conklin, Chris M. J.
    Craddock, Kenneth J.
    Have, Cherry
    Laskin, Janessa
    Couture, Christian
    Ionescu, Diana N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) : 45 - 51
  • [8] BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations
    Costa, Daniel B.
    Halmos, Balazs
    Kumar, Amit
    Schumer, Susan T.
    Huberman, Mark S.
    Boggon, Titus J.
    Tenen, Daniel G.
    Kobayashi, Susumu
    [J]. PLOS MEDICINE, 2007, 4 (10): : 1669 - 1680
  • [9] Dacic S, 2011, ARCH PATHOL LAB MED, V135, P622, DOI 10.1043/2010-0625-RAIR.1
  • [10] A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer
    Ellis, Peter M.
    Blais, Normand
    Soulieres, Dennis
    Ionescu, Diana N.
    Kashyap, Meenakshi
    Liu, Geoff
    Melosky, Barb
    Reiman, Tony
    Romeo, Phillippe
    Shepherd, Frances A.
    Tsao, Ming-Sound
    Leighl, Natasha B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (08) : 1379 - 1391
1234